119 filings
8-K
NVCR
NovoCure Ltd
2 May 24
Novocure Reports First Quarter 2024 Financial Results
7:01am
8-K
NVCR
NovoCure Ltd
27 Mar 24
Regulation FD Disclosure
7:00am
8-K
NVCR
NovoCure Ltd
22 Feb 24
Novocure Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
7:06am
8-K
NVCR
NovoCure Ltd
18 Jan 24
Novocure Announces FDA Acceptance of the PMA Application for TTFields Therapy in Non-Small Cell Lung Cancer
7:01am
8-K
NVCR
NovoCure Ltd
9 Jan 24
Novocure Announces Last Patient Enrolled in Phase 3 TRIDENT Trial in Newly Diagnosed Glioblastoma
7:00am
8-K
o7c6jf1673n3falf
8 Jan 24
Novocure Announces Preliminary Full Year and Fourth Quarter 2023 Net Revenues and Provides Company Update
7:10am
8-K
9h4r2eh15zkz1s o7
4 Jan 24
Novocure Appoints Dr. Nicolas Leupin as Chief Medical Officer
4:10pm
8-K
d3ng o3tgd
28 Nov 23
Regulation FD Disclosure
7:30am
8-K
plz dhij4haqw1bz9by1
26 Oct 23
Novocure Reports Third Quarter 2023 Financial Results
7:03am
8-K
xhru zg8t2up
28 Aug 23
Regulation FD Disclosure
7:00am
8-K
xze8q601oq5h
27 Jul 23
Novocure Reports Second Quarter 2023 Financial Results
7:03am
8-K
jy5pc7ebd p7
21 Jul 23
Regulation FD Disclosure
8:00am
8-K
cm5e0hmizoao
8 Jun 23
Departure of Directors or Certain Officers
4:12pm
8-K
iha0igsyqfkr3g
6 Jun 23
Regulation FD Disclosure
3:45pm
8-K
4hnoiayr11ncb
6 Jun 23
Regulation FD Disclosure
12:18pm
8-K
r9kbgnj5uvq
6 Jun 23
Regulation FD Disclosure
8:00am
8-K
gtydh1vo 0zqh0svur
4 May 23
Novocure Reports First Quarter 2023 Financial Results
7:02am
8-K
7q02 cbcwt
26 Apr 23
Regulation FD Disclosure
10:03am
8-K
qf1pe wjdn
29 Mar 23
Kristin Stafford Joins Novocure Board of Directors
7:31am
8-K
gz3k 4s905
23 Feb 23
Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
7:04am